PETALING JAYA – The prospect of cannabis legalization for medicinal purposes in Singapore appears remote, according to Minister for Home Affairs and Law, K. Shanmugam. This statement follows Thailand’s recent decision to become the first Asian nation to decriminalize cannabis nationwide.
Singapore’s Stance on Cannabis
In a virtual interview with The Star, Mr. Shanmugam emphasized that Singapore’s policies regarding cannabis are rooted in scientific research, indicating that cannabis is “clearly harmful and addictive.” He expressed caution against adopting a more lenient approach, stating:
“Our policies are based on science and research… We will not be influenced by others to ease provisions in the law for health purposes.”
Cautious Evaluation of Medical Claims
The Minister showed skepticism towards pharmaceutical companies advocating the medical benefits of cannabis.
- “If a pharmaceutical company is pushing for the use of cannabis on the basis that it has medical benefits, I would be very sceptical,” he stated.
- He also warned against non-governmental organizations with ties to these firms advocating for cannabis use.
Ultimately, Shanmugam noted that any potential medical use of cannabis would depend on assessments made by medical professionals:
“If a reputed medical association says they need cannabis for medical use, then we will take it very seriously.”
Regional Developments in Cannabis Legislation
Malaysia’s Approach
While Singapore remains hesitant, Malaysia is exploring the possibility of incorporating cannabis and kratom leaves for medical applications. Health Minister Khairy Jamaluddin recently conducted a working visit to Thailand to:
- Evaluate potential uses of cannabis and kratom for medical purposes.
- Examine the legal framework surrounding their medical use.
Furthermore, the Malaysian government plans to establish a framework to register certain cannabidiol products by next year.
Concerns Raised by Thailand’s Legalization
Shanmugam pointed out that Thailand’s decriminalization has led to unforeseen challenges, including:
- A surge of cannabis products in various consumer goods, including toothpaste and snacks.
- The governor of Bangkok’s directive for schools to be cannabis-free and a public smoking ban.
He highlighted that the Thai government is now grappling with the implications of its earlier decisions, emphasizing the complexities in the implementation of cannabis laws.
Healthcare and Economic Concerns
Mr. Shanmugam also underscored the economic fallout observed in other nations where cannabis is legalized:
“Countries may feel they can tax the trade, but the expenditures on healthcare often exceed the tax benefits.”
This raises pertinent questions regarding the long-term implications of cannabis legalization that are yet to be resolved.
Public Sentiment in Singapore
In gauging public opinion, the Minister noted that significant surveys indicate:
- The majority of Singaporeans prefer to maintain strict regulations surrounding cannabis.
- Concerns exist about possible societal consequences if cannabis use becomes more prevalent.
With these factors in consideration, Singapore remains committed to a cautious and evidence-based approach regarding cannabis policies. The ministers affirm that substantial evidence and recommendations from medical professionals will be paramount for any future discussions on potential cannabis use for treatment and recovery.
